About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Nes-cre/ERT2)5-1Imayo
transgene insertion 5-1, Itaru Imayoshi
MGI:3641212
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Hes1tm1Kag/Hes1tm1Kag
Hes3tm1Kag/Hes3tm1Kag
Hes5tm1Fgu/Hes5tm1Fgu
Tg(Nes-cre/ERT2)5-1Imayo/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA MGI:3808127
cn2
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Nes-cre/ERT2)5-1Imayo/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:4413349
cn3
Ezh2tm1Yugo/Ezh2tm1Yugo
Tg(Nes-cre/ERT2)5-1Imayo/0
involves: C57BL/6 MGI:4413347
cn4
Eno2tm1(DTA)Hsak/Eno2tm1(DTA)Hsak
Tg(Nes-cre/ERT2)5-1Imayo/0
involves: C57BL/6 MGI:3817328
cn5
Hbp1tm1.1Ohts/Hbp1tm1.1Ohts
Tg(Nes-cre/ERT2)5-1Imayo/0
involves: C57BL/6 * CBA/JNCrlj * ICR MGI:6361945


Genotype
MGI:3808127
cn1
Allelic
Composition
Hes1tm1Kag/Hes1tm1Kag
Hes3tm1Kag/Hes3tm1Kag
Hes5tm1Fgu/Hes5tm1Fgu
Tg(Nes-cre/ERT2)5-1Imayo/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hes1tm1Kag mutation (2 available); any Hes1 mutation (21 available)
Hes3tm1Kag mutation (2 available); any Hes3 mutation (18 available)
Hes5tm1Fgu mutation (1 available); any Hes5 mutation (16 available)
Tg(Nes-cre/ERT2)5-1Imayo mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• mice exhibit no change in Cajal-Retzius cell number




Genotype
MGI:4413349
cn2
Allelic
Composition
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Nes-cre/ERT2)5-1Imayo/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rnf2tm1Mvi mutation (1 available); any Rnf2 mutation (36 available)
Tg(Nes-cre/ERT2)5-1Imayo mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• following exposure to tamoxifen at E13.5, the late-born/upper-layer neurons in the cortical plate at P6.5 that had been labeled with BrdU at E19.0 is greater than in control Rnf2tm1Mvi homozygotes

cellular
• following exposure to tamoxifen at E13.5, the late-born/upper-layer neurons in the cortical plate at P6.5 that had been labeled with BrdU at E19.0 is greater than in control Rnf2tm1Mvi homozygotes




Genotype
MGI:4413347
cn3
Allelic
Composition
Ezh2tm1Yugo/Ezh2tm1Yugo
Tg(Nes-cre/ERT2)5-1Imayo/0
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ezh2tm1Yugo mutation (1 available); any Ezh2 mutation (71 available)
Tg(Nes-cre/ERT2)5-1Imayo mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• following tamoxifen treatment at E13.5 and E14.5, the number of S100beta+ cells are reduced in the neocortex at P1.5 compared to in similarly treated control mice

cellular
• following tamoxifen treatment at E13.5 and E14.5, the number of S100beta+ cells are reduced in the neocortex at P1.5 compared to in similarly treated control mice




Genotype
MGI:3817328
cn4
Allelic
Composition
Eno2tm1(DTA)Hsak/Eno2tm1(DTA)Hsak
Tg(Nes-cre/ERT2)5-1Imayo/0
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eno2tm1(DTA)Hsak mutation (1 available); any Eno2 mutation (53 available)
Tg(Nes-cre/ERT2)5-1Imayo mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• 3 weeks following treatment with tamoxifen, mice exhibit ablation of newly formed neurons in the olfactory bulb that becomes more severe at 6 and 12 weeks of treatment
• following treatment with tamoxifen, mice exhibit ablation of newly forming neurons
• following treatment with tamoxifen, neuroblasts at the entry site of the rostral migratory stream exhibit markers of apoptosis
• 3 weeks following treatment with tamoxifen, mice exhibit ablation of newly formed neurons in the olfactory bulb that becomes more severe at 6 and 12 weeks of treatment
• following treatment with tamoxifen, mice exhibit a loss of granule cells in deep regions while superficial neurons are preserved
• 3 weeks following treatment with tamoxifen, mice exhibit loss of granule neurons in the olfactory bulb
• following treatment with tamoxifen, mice exhibit decreased granule cell density in the dentate gyrus compared to in wild-type mice

behavior/neurological
N
• despite ablation of olfactory neurons, mice exhibit normal behavior towards wild-type mice and normal odor-associated memory




Genotype
MGI:6361945
cn5
Allelic
Composition
Hbp1tm1.1Ohts/Hbp1tm1.1Ohts
Tg(Nes-cre/ERT2)5-1Imayo/0
Genetic
Background
involves: C57BL/6 * CBA/JNCrlj * ICR
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hbp1tm1.1Ohts mutation (0 available); any Hbp1 mutation (41 available)
Tg(Nes-cre/ERT2)5-1Imayo mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• marked increase in Pax6+, Tbr2+ and Tuj1+ populations following tamoxifen administration at E9.5
• telencephalic wall appears thinner following tamoxifen administration at E9.5
• telencephalic vesicles are remarkably dilated at E14.5, E16.5 and E18.5 following tamoxifen administration at E9.5
• volume of the ventral telencephalon is reduced and the wall of the dorsal telencephalon is thinner after E14.5 following tamoxifen administration at E9.5
• the ventricular surface area in the dorsolateral telencephalon (cortical region) is enlarged following tamoxifen administration at E9.5
• neuronal layer (Tuj1+) is thinner compared to controls following tamoxifen administration at E9.5
• thickness of cortical neuronal layers is reduced at all stages following tamoxifen administration at E9.5
• appears to be stretched in the tangential direction following tamoxifen administration at E9.5
• thinner following tamoxifen administration at E9.5
• hypoplastic or absent at E18.5 following tamoxifen administration at E9.5
• hypoplastic or absent at E18.5 following tamoxifen administration at E9.5
• hypoplastic or absent at E18.5 following tamoxifen administration at E9.5
• hypoplastic or absent at E18.5 following tamoxifen administration at E9.5
• increase in the number of neuronal stem cells at E14.5 following tamoxifen administration at E9.5
• rapid depletion of neuronal stem cell pool between E14.5 and E16.5 following tamoxifen administration at E9.5
• decrease in the number of Tbr2+ and early born neurons in cortical regions at E12.5 following tamoxifen administration at E9.5 indicating a delay in onset of neurogenesis
• proportional decrease in cortical neurons in all layers following tamoxifen administration at E9.5
• at E12.5 neuronal stem cells continue to expand by symmetric divisions following tamoxifen administration at E9.5
• cell cycle length is reduced in the cortex at all stages examined following tamoxifen administration at E9.5

cellular
• neuronal stem cell cell cycle length is reduced in the cortex at all stages examined following tamoxifen administration at E9.5
• marked increase in Pax6+, Tbr2+ and Tuj1+ populations following tamoxifen administration at E9.5





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory